This paper examines the current landscape of peptide-based medicines, exploring their biological mechanisms, clinical applications, safety considerations, and regulatory pathways
Based on Phase 2 trial data (Jastreboff et al., NEJM , 2023), diarrhoea was reported in a meaningful proportion of participants treated with retatrutide, with incidence increasing in a dose-dependent manner
We're here to help you make the best decisions for your health or your patients' health
When prescribed and monitored by medical professionals, these treatments are safe and well-tolerated for many patients
Semaglutide with B12 alone addresses nausea management and nutrient protection but does not include the muscle-preserving benefits of glycine
GLP-1-induced renal vasodilation in rodents depends exclusively on the known GLP-1 receptor and is lost in prehypertensive rats